MedTrace Logo

Powder Topical Rifampicin on Reducing Infections After Neural Tube Defect Surgery in Infants

NCT03198819 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-06-26

No results posted yet for this study

Summary

The correct timing and technique of neural tube defect (NTD) repairs significantly decreases the morbidity and mortality of NTD cases. However, infections related to the surgery are still common. We investigated the effects of topical rifampicin (RIF) combined with routine prophylaxis in newborns with open NTD.

Conditions

  • Postoperative Infection Rates

Interventions

DRUG

Local Rifampisin and İnrtravenous cefotaxime

Sponsors & Collaborators

  • Yuzuncu Yıl University

    lead OTHER

Principal Investigators

  • nihat demir · yüzüncüyıl üniversitesi

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-11-30
Completion
2017-12-31
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03198819 on ClinicalTrials.gov